Financhill
Back

Bio-Path Holdings Quote, Financials, Valuation and Earnings

Sell
11

BPTH
Bio-Path Holdings

Last Price:
2.12
Seasonality Move:
-15.37%

7 Day Trial

ALL ACCESS PASS

$ 7

Bio-Path Holdings Price Quote

$2.12
-0.01 (-4.93%)
(Updated: June 13, 2024 at 4:57 AM ET)

Bio-Path Holdings Key Stats

Sell
11
Bio-Path Holdings (BPTH) is a Sell

Day range:
$2.10 - $2.28
52-week range:
$1.85 - $44.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
87.5K
Avg. volume:
2.1M
1-year change:
-93.55%
Market cap:
$3.5M
Revenue:
$0
EPS:
$-26.11

How Much Does Bio-Path Holdings Make?

Data Unavailable

Is Bio-Path Holdings Growing As A Company?

Data Unavailable

Bio-Path Holdings Stock Price Performance

  • Did Bio-Path Holdings Stock Go Up Last Month?
    Bio-Path Holdings share price went down by -21.69% last month
  • Did BPTH's Share Price Rise Over The Last Year?
    BPTH share price fell by -93.55% over the past 1 year

What Is Bio-Path Holdings 52-Week High & Low?

Bio-Path Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bio-Path Holdings?

  • How Much Debt Does Bio-Path Holdings Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Bio-Path Holdings Have?
    Cash and short term investments quarterly total is $188K
  • What Is Bio-Path Holdings’s Book Value Per Share?
    Book value per share is -3.48

Is Bio-Path Holdings Cash Flow Positive?

  • What Is BPTH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.9M
  • What Is Bio-Path Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Bio-Path Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Bio-Path Holdings Return On Invested Capital

Data Unavailable

Bio-Path Holdings Earnings Date & Stock Price

Bio-Path Holdings Competitors

  • Who Are Bio-Path Holdings's Competitors?
    Below is a list of companies who compete with Bio-Path Holdings or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • EyePoint Pharmaceuticals Inc (EYPT)
    • INVO Bioscience Inc (INVO)
    • Microbot Medical Inc (MBOT)
    • Palatin Technologies Inc (PTN)

Bio-Path Holdings Dividend Yield

Data Unavailable

Bio-Path Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -7.49%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 20.00
Upside from Last Price: 838.97%

Major Shareholders

  • How many BPTH shares are owned by institutional investors?
    80.8K BPTH shares are owned by institutional investors
  • How many BPTH shares are owned by insiders?
    9.5M BPTH shares are owned by insiders